TITLE

TRANSJUGULAR LIVER BIOPSY: SAFETY, ADEQUACY AND CLINICAL IMPACT IN A NON-TRANSPLANT CENTRE

AUTHOR(S)
Elsharkawy, A.M.; Austin, A.S.; Ryder, S.D.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA35
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Histological examination of liver tissue is the gold standard for diagnosing and staging liver disease. We assessed the safety, efficacy, and clinical impact of transjugular liver biopsy (TJBx) in a non-transplant centre. Methods: 180 consecutive biopsies were performed using an automated transjugular cutting biopsy needle with a maximum core length of 25 mm and diameter of 2.2 mm. Mean patient age was 54.2 ± 13.8 (17-89) of whom 114 were male. Results: Indications for TJBx were platelet count < 100 × 109/I (49%), INR > 1.4 (41%), bilirubin > 100 µmol/I (35%), tense ascites (23%) or other (17%). 44% had two or more indications. Minor transient complications occurred in 11 cases only (5 hypotension, 4 pain, 2 fever). Biopsy sample was adequate for histological diagnosis in 93%, inadequate in 4%, and technically unsuccessful in 2%. Mean biopsy size was 14.8 ± 0.6 (5-35) mm. Adequacy and length did not differ beh, veen cirrhotic and non-cirrhotic biopsies. In 63% of cases, alcoholic liver disease was the presumed diagnosis before biopsy. TJBx had a clinical impact in 78%; changed diagnosis in 38% (drug induced liver injury 11, haemachromatosis 8, normal liver 6, cryptogenic cirrhosis 5, other 39); and changed stage in 40%. The likelihood of a change in diagnosis was greater in the non-cirrhotic 21/64 compared with the cirrhotic 35/116 (Chi test; p = 0.001). In addition, a change in diagnosis was less common in those with a presumptive diagnosis of alcoholic liver disease 25/113 compared with those without 44/67 (Chi test; p < 0.001). Conclusions: Transjugular liver biopsy is a safe procedure in high risk patients in a non-transplant centre. It provides adequate tissue samples in the vast majority irrespective of the presence or absence of cirrhosis. It has a clinical impact in 78% leading to an unsuspected diagnosis in 38%.
ACCESSION #
9747496

 

Related Articles

  • FibroScan: A Noninvasive Test of Liver Fibrosis Assessment. Al-Ghamdi, Abdullah S. // Saudi Journal of Gastroenterology;Jul2007, Vol. 13 Issue 3, p147 

    Determination of the extent of progress of hepatic fibrosis is important in clinical practice, where it may reflect the severity of liver disease and predict response to treatment. Percutaneous liver biopsy is the gold standard for grading and staging of liver disease. However, liver biopsy is...

  • THE HARUSPEX AND PRIMARY BILIARY CIRRHOSIS. Schaffner, Fenton // American Journal of Gastroenterology;Jul1989, Vol. 84 Issue 7, p711 

    Presents a study which estimated the course of primary biliary cirrhosis. Reason for the increase in the number of patients with biliary cirrhosis; Factors used in each of the various schemes to estimate prognosis in primary biliary cirrhosis; Issue on whether a liver biopsy is needed in the...

  • Rare Associations Of Primary Biliary Cirrhosis: A Review Article. Rodriguez, Tomas; Latour, Euyen; Patel, Pikeshkumar; Niazi, Masooma; Bloom, Alan; Balar, Bhavna; Carvajal, Simeon // Internet Journal of Gastroenterology;2008, Vol. 7 Issue 1, p13 

    Primary Biliary Cirrhosis (PBC) is the most common chronic cholestatic liver disease in adults in the United States (16). There are several rare conditions associated with PBC. We review all reported associations and present our own case experience. The list of these conditions is extensive but...

  • Second Opinion Pathology in Liver Biopsy Interpretation. Bejarano, Pablo A.; Koehler, Alison; Sherman, Kenneth E. // American Journal of Gastroenterology;Nov2001, Vol. 96 Issue 11, p3158 

    OBJECTIVE: Clinical management of liver diseases is often based on the interpretation of the pathologist examining liver biopsies. Many pathologists have little formal training and experience with these tissues. The magnitude of this problem is not determined yet. The goal of this study was to...

  • Bleeding hepatic pseudoaneurysm complicating percutaneous liver biopsy with interventional treatment options. Own, Ahmed; Balzer, Joern; Vogl, Thomas // European Radiology;Jan2005, Vol. 15 Issue 1, p183 

    Describes a case of a patient with bleeding hepatic pseudoaneurysm complicating percutaneous liver biopsy. Ultrasound examination of the abdomen; Transarterial angiography with selective and super-selective catheter placement in the celiac artery; Investigation of hepatosplenomegaly with liver...

  • Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis. Yilmaz, Yusuf; Kedrah, Alla Eldeen; Ozdogan, Osman; Ikejima, Kenichi // World Journal of Gastroenterology;9/21/2009, Vol. 15 Issue 35, p4387 

    Nonalcoholic fatty liver disease (NAFLD) remains a leading cause of chronic liver disease. In the context of NAFLD, the presence of nonalcoholic steatohepatitis (NASH) portends an adverse prognosis with greater risk of liver fibrosis and cirrhosis. Although liver biopsy is the keystone of...

  • Reversal of Liver Fibrosis. Ismail, Mona H.; Pinzani, Massimo // Saudi Journal of Gastroenterology;Jan2009, Vol. 15 Issue 1, p72 

    Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the...

  • SMALL BOWEL ABSORPTION IN PORTAL CIRRHOSIS WITH ASCITES. Friedman, Abraham I.; McEwan, Guillermo // American Journal of Gastroenterology;Feb1963, Vol. 39 Issue 2, p114 

    Presents a study which determined whether defects in small bowel absorption contribute to the development of portal cirrhosis. Health conditions associated with liver dysfunction; Result of the small bowel biopsies performed; Function of the instestinal tract.

  • Development and evaluation of a nurse-led transient elastography service for the staging of hepatic fibrosis in patients with suspected chronic liver disease. McCorry, R.B.; Palaniyappan, N.; Chivinge, A.; Kaye, P.; James, M.W.; Aithal, G.P. // QJM: An International Journal of Medicine;Aug2012, Vol. 105 Issue 8, p749 

    Background and Aims: Establishing the presence of fibrosis and cirrhosis is an essential step in the management of patients with chronic liver diseases (CLD). Liver stiffness measurement (LSM) based on transient elastography (TE) correlates well with the stages of liver fibrosis and has been...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics